Searched for
IMPAX LABORATORIES
Alembic Pharma gets USFDA nod for generic productAlembic Pharmaceuticals has received approval from the USFDA to market Albendazole Tablets USP (200 mg), a generic drug for treating infect...- Stocks in the news: Sadbhav Infra, Delta Corp, IDBI Bank, RIL, DLF and Alok IndIOL Chemicals said it will set up an ancillary facility at Raikot in Punjab .
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
- Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offersIf successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Dr Reddy's reach settlement with Wyeth over EffexorDr Reddy's Laboratories has reached a deal with Wyeth LLC over a patent litigation involving generic version of blockbuster anti-depressant...
- Ranbaxy's new sales drive fails to pay offRanbaxy by revenues has recorded the slowest domestic sales growth rate among its peers in the first seven months of this year, despite boo...
- Ranbaxy loses out on FDA delayRanbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on Mar...
- Drug firms fight with foreign cos over patentsPharma companies are at loggerheads with their foreign counterparts over patent rights. Global pharma giants have been filing cases against...
- Wyeth's 'nod' to Sun generic may be tacticalWyeth’s decision to issue a covenant ‘not-to-sue’ (CNS) to Sun Pharmaceutical Industries for seeking approval to sell its version of anti-d...
Load More
